Gene therapy for ventricular tachyarrhythmias.

about

Gene and cell therapies for the failing heart to prevent sudden arrhythmic death Gene therapies for arrhythmias in heart failure.Gene therapy to restore electrophysiological function in heart failure.In vivo reprogramming for heart disease

P2860

Q26865425-36386BFB-BE1F-4532-B21F-3496EE58120E Q33804951-D00BD9E5-25EF-4AC4-82C9-8BB127B0CE5B Q38416938-61C36227-DB03-4D5D-960A-D454412EF46D Q41286366-B7CE7B80-6763-45C1-968C-B9F5B6C53F37

P2860

Gene therapy for ventricular tachyarrhythmias.

Item

http://www.wikidata.org/entity/Q36726175

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Gene therapy for ventricular tachyarrhythmias.

@ast

Gene therapy for ventricular tachyarrhythmias.

@en

type

Item

label

Gene therapy for ventricular tachyarrhythmias.

@ast

Gene therapy for ventricular tachyarrhythmias.

@en

prefLabel

Gene therapy for ventricular tachyarrhythmias.

@ast

Gene therapy for ventricular tachyarrhythmias.

@en

P1476

Gene therapy for ventricular tachyarrhythmias.

@en

P2093

J K Donahue

http://www.w3.org/2001/XMLSchema#string

P2860

The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

Transient Ca2+ depletion of the sarcoplasmic reticulum at the onset of reperfusion.

Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome.

Cardiac ionic currents and acute ischemia: from channels to arrhythmias.

Inositol 1,4,5-trisphosphate and reperfusion arrhythmias.

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol.

SERCA2a gene transfer decreases sarcoplasmic reticulum calcium leak and reduces ventricular arrhythmias in a model of chronic heart failure.

Molecular ablation of ventricular tachycardia after myocardial infarction.

P2888

gt.2012.35

P304

600-605

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/GT.2012.35

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224845945

http://www.w3.org/2001/XMLSchema#string

P698

22534468

http://www.w3.org/2001/XMLSchema#string

P921

gene therapy

P932

3611327

http://www.w3.org/2001/XMLSchema#string

Gene therapy for ventricular tachyarrhythmias.

about

P2860

P2860

Gene therapy for ventricular tachyarrhythmias.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932